Faculty

Horizons in vascular disease prevention and treatment
Prof. Chris Packard


Non-invasive imaging of inflammation in the atherosclerotic plaque using 18-fluorodeoxyglucose positron emission tomography – can it deliver?
Dr. John Davies


Nuclear Receptors as targets in the treatment of atherosclerosis and related disorders
Dr. Philippe Gervois


Nuclear Receptor Signalling and Design of Modulators
Dr. Bill Cairns


Lp-PLA2 as a potential therapeutic target for atherosclerosis
Dr. Colin Macphee


Disruption of the Cathepsin K gene reduces atherosclerosis progression, induces plaque fibrosis, but accelerates macrophage foam cell formation
Prof. Mat Daemen


Challenges for drug discovery in stroke, a pre-clinical perspective
Dr. Hugh Marston


Reading the entrails of a decade of stroke trials: how do we get it right next time?
Dr. Keith Muir

 

 
 
 

Webcast produced by Prous Science
RealNetworks, RealPlayer and RealAudio are trademarks of RealNetworks, Inc.